In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

About The Study: In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of ...

World Pneumonia Day, celebrated annually on November 12th, emphasises the worldwide health burden of pneumonia, a lung infection that affects millions of people, mainly children and the elderly. While ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Health Canada's approval is based on data from the Phase 3 clinical trial ConquerRSV, a global study conducted in approximately 37,000 adults aged 60 years and older in 22 countries. No serious safety ...

there are now some very real concerns about a lesser-known virus – respiratory syncytial virus, or RSV. 1 Although RSV can affect both adults and infants, the majority of general awareness and ...

Research found RSV (respiratory syncytial virus), leads to mild respiratory symptoms ... Importantly, our study suggests that ...

In the U.S., wastewater surveillance for public health became vital during the COVID-19 pandemic, when the U.S. Centers for Disease Control and ...

WHO study lists top endemic pathogens for which new vaccines are urgently needed: Geneva, Switzerland Thursday, November 7, 2024, 09:00 Hrs [IST] A new World Health Organization ( ...

WHO study identifies 17 priority pathogens for new vaccines, including HIV, malaria, and tuberculosis, to save lives globally.